Mounjaro®
Starting from £179.99/mo
Start journey Learn moreBloating on Mounjaro is real, but it is not a sign the medicine is harming you. The stomach discomfort, fullness and trapped wind that many people notice in the first weeks of treatment are tied directly to how tirzepatide works — and for most people they ease off as the body adjusts. Mounjaro is a GIP and GLP-1 receptor agonist that slows gastric emptying, and that mechanical change is the main reason food and gas move through your gut more slowly than usual. It is a prescription-only medicine, so any persistent or severe symptoms are worth raising with the prescriber who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who contact their clinic about Mounjaro bloat assume something has gone wrong. In fact, the opposite is closer to the truth. Tirzepatide deliberately slows the rate at which your stomach empties — that is a core part of how it reduces hunger and helps you eat less. When food lingers longer in the stomach, gas builds up alongside it. The result is the tight, uncomfortable fullness that patients often describe as bloating, and which can be accompanied by burping or wind.
This is not an allergic reaction, not organ damage, and not a reason to stop treatment without speaking to your prescriber first. The NHS medicines page for tirzepatide lists bloating, indigestion and burping among the common side effects, alongside nausea and constipation. Common here carries its clinical meaning: it affects between one in ten and one in one hundred users. Knowing that does not make it comfortable, but it does reframe it.
The other frequent misconception is that bloating gets worse the longer you take Mounjaro. For the majority of people, the opposite is true. Symptoms tend to peak when a dose is first introduced or increased, then gradually ease as the gut adapts. If you are bloated on Mounjaro at week four or five with no improvement at all, that is worth a conversation with your prescriber, not silent endurance.
Many people tolerate their first pen, at the 2.5mg starting level, fairly well. The starter dose exists primarily to let the body adjust before any meaningful therapeutic effect kicks in. Bloating tends to flare when the dose steps up (to 5mg, to 7.5mg, and so on) because each increase sharpens the gastric-emptying effect before the gut has recalibrated.
This pattern is useful to know in advance. If you have been managing well and then feel noticeably more bloated after moving up, that is likely the expected adjustment rather than a new problem. Most people find it settles within one to two weeks. Whether to hold a dose for longer before stepping up is a clinical decision, if you are finding increases particularly rough, raise it with your prescriber rather than adjusting your own timing. For a fuller picture of how tirzepatide works across the full dose schedule, the Mounjaro treatment page covers the mechanism and the licensed titration pathway in plain terms.
One practical note that our prescribers hear from patients regularly: the bloating is often worst if you eat a large or fatty meal, or drink something carbonated, close to your injection day. Some people find spacing a bigger meal to a different point in the week gives their gut an easier run. That alone is not a protocol, but it reflects a pattern worth testing.
There is no single fix, but there are several adjustments that consistently seem to help. Smaller, more frequent meals put less demand on a stomach that is already emptying slowly. High-fat foods and very fibrous vegetables (both nutritious in their own right) can add to gas load when digestion is sluggish, so temporarily moderating them during a flare can give some relief. Fizzy drinks add gas directly and are probably worth avoiding on difficult days.
Eating slowly and chewing properly sounds obvious, but it makes a material difference when gastric capacity is reduced. Some people find sitting upright for at least thirty minutes after eating helps. Light walking after meals (not a gym session, just a stroll) gently encourages gut motility.
For more detailed strategies around eating patterns, our page on managing bloating on Mounjaro goes into the practical side in more depth. And if it is wind specifically that is the main problem rather than the pressure sensation, the Mounjaro bloating and gas page addresses that separately.
One thing worth tracking: write down what you ate and when you felt most uncomfortable. If you want to understand why Mounjaro bloating follows the patterns it does, spotting whether a particular food or a particular time of day relative to your injection is involved gives you something concrete to work with rather than just a general sense that your stomach is unhappy. Patients who do this tend to find their own triggers faster than those who try generic elimination.
Ordinary bloating, wind and burping do not require an urgent call. But some symptoms that can be mistaken for ordinary GI discomfort are worth acting on faster. Severe or persistent stomach pain that radiates through to the back, with or without vomiting, should be assessed promptly, this is one of the patterns associated with acute pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026. Pancreatitis is rare, but it is serious. Similarly, if you are vomiting frequently enough that you cannot keep fluids down, that is dehydration risk territory and needs medical attention.
Persistent discomfort that is not improving and is affecting your day-to-day life is also a reasonable prompt to contact your prescriber. It may point to a dose-timing issue, a dietary factor you have not spotted, or occasionally a need to hold a titration step. The right response is a clinical conversation, not a prolonged wait. If you are on treatment through nume, the aftercare team is available seven days a week, details on the contact page.
For anyone still weighing up whether Mounjaro is the right route, our consultation page sets out how the process works: a prescriber reviews your case the same day, with no waiting list and no algorithm making the call.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.